Meeting
2019 Gastrointestinal Cancers Symposium
The effect of adjuvant chemotherapy for stage III colon cancer in elderly patients.
Authors
Naomi Hayashi
Department of Surgery, Tosei General Hospital, Seto, Japan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 611)
DOI
10.1200/JCO.2019.37.4_suppl.611
Abstract #
611
Poster Bd #
J14
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Time-dependent patterns of recurrence and death in resected colon cancer (CC): Pooled analysis of 12,223 patients from modern trials in the ACCENT database containing oxaliplatin.
First Author: Lindsay A. Renfro
Poster
2021 Gastrointestinal Cancers Symposium
Adjuvant chemotherapy (AC) choices: An analysis of elderly Australian patients with stage III colorectal cancer (CRC).
First Author: Oliver Piercey
Poster
2020 Gastrointestinal Cancers Symposium
Benefit of oxaliplatin in stage III colon cancer according to IDEA risk groups: Analysis of MOSAIC and C-07 trials.
First Author: Ofer Margalit
Poster
2018 Gastrointestinal Cancers Symposium
Prospective multicenter study of the impact of the 12-gene assay recurrence score on adjuvant chemotherapy treatment recommendations for stage II/III colon cancer in the post-IDEA era: SUNRISE-Decision Impact study.
First Author: Takeharu Yamanaka